Bruker Corporation (BRKR) To Go Ex-Dividend on March 23rd

Bruker Corporation (NASDAQ:BRKR) declared a quarterly dividend on Thursday, February 19th. Shareholders of record on Monday, March 23rd will be paid a dividend of 0.05 per share by the medical research company on Tuesday, April 7th. This represents a c) annualized dividend and a yield of 0.6%. The ex-dividend date is Monday, March 23rd.

Bruker has raised its dividend payment by an average of 0.0%annually over the last three years. Bruker has a payout ratio of 7.3% meaning its dividend is sufficiently covered by earnings. Analysts expect Bruker to earn $3.15 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 6.3%.

Bruker Stock Down 0.9%

NASDAQ BRKR opened at $33.33 on Friday. The business has a fifty day moving average price of $41.57 and a two-hundred day moving average price of $41.00. The stock has a market capitalization of $5.07 billion, a PE ratio of -222.17, a PEG ratio of 2.01 and a beta of 1.19. Bruker has a fifty-two week low of $28.53 and a fifty-two week high of $56.22. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.73 and a quick ratio of 0.87.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Thursday, February 12th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.06). Bruker had a negative net margin of 0.25% and a positive return on equity of 13.56%. The business had revenue of $977.20 million during the quarter, compared to the consensus estimate of $964.61 million. During the same quarter in the previous year, the business posted $0.76 EPS. The company’s revenue for the quarter was down .2% on a year-over-year basis. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Equities analysts expect that Bruker will post 2.69 earnings per share for the current fiscal year.

Bruker Company Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.